Trade Summary

3 days ago, Dugel Pravin, serving as See Remarks at OCULAR THERAPEUTIX, INC (OCUL), sold 21,156 shares at $8.20 per share, for a total transaction value of $173,479.20. Following this transaction, Dugel Pravin now holds 2,597,170 shares of OCUL.

This sale represents a 0.81% decrease in Dugel Pravin's stake in the company.

The trade was executed on Tuesday, May 26, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, May 28, 2026 at 4:08 PM ET, 2 days after the trade was made.

OCULAR THERAPEUTIX, INC operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.